Posts Tagged: "International"

U.S. Patent System Holds Steady in Second Place in 2020 International IP Rankings

The U.S. Chamber of Commerce Global Innovation Policy Center (GIPC) released its eighth annual International IP Rankings. The United States achieved the top overall ranking as the strongest intellectual property regime in the world. The U.S. also tied for second place in the patent specific worldwide rankings with Japan, South Korea and Switzerland. In first place again this year for patents was Singapore, which marks the third consecutive year Singapore has achieved recognition as the top overall patent jurisdiction in the world.

How China Will Fundamentally Change the Global IP System

Currently, the massive volume of filings at the Chinese Patent Office (CNIPA) exceeds the filings of the next four most active patent offices combined. It portends a rapid shift to Chinese language prior art being the repository of technical teachings around leading edge technologies for the Fourth Industrial Revolution. This will happen for several reasons and much more rapidly than…

Proxy Wars: Standard Essential Patents in IP Litigation

Join Gene Quinn, President & CEO of IPWatchdog, Inc., for a wide-ranging discussion on the issue of Standard Essential Patents, Standard Setting Organizations, Fair Reasonable and Non-Discriminatory (FRAND) licensing requirements and related Antitrust investigations. Joining Gene will be Theodore Essex, former Administrative Law Judge for the International Trade Commission (ITC), and current Senior Counsel at Hogan Lovells.

A Journey Through the Chinese Patent System: The differences in how patent rights are treated

The trade dispute between the US and China started with a US accusation of intellectual property theft on the part of China.  Is China really “stealing” intellectual property?  I’m not so sure.  Perhaps the Chinese are stealing trade secrets, and if parties are engaged in such activities they should be punished, but there is a lot of taking that has been legitimized – even authorized – by the Congress and the Supreme Court in recent years.  U.S. patent law is today enabling foreign corporations, including Chinese corporations, to legitimately take intellectual property developed in the U.S.  That is not theft.  It’s just business.  And far more damage is being done to the U.S. as the result of legalized appropriation of patented innovations than could ever be done by the theft of trade secrets.

Innovators and Content Creators Urge USTR Lighthizer to Fight for Strong IP in NAFTA Negotiations

ACTION for Trade asks Lighthizer to consider advocating for strong IP protections and robust enforcement to benefit a diverse group of industries, including digital content producers and distributors, biopharmaceutical firms and software developers… Along with strong patent policy, ACTION for Trade calls for the establishment of regulatory data protection (RDP) provisions which are consistent with U.S. law, especially where medical innovations are concerned. The letter to USTR Lighthizer notes that U.S. law recognizes a 12-year period of RDP for biologic treatments and a 5-year period of RDP for small molecule treatments. Such provisions would allow the original innovators of novel medicines to submit data on the safety and efficacy of medicines while shielding that data from others who might produce generics based on the data.